Dabigatran (Pradaxa) Is Safe for Extended Venous Thromboembolism Prophylaxis After Surgery for Pancreatic Cancer.
M Farzan RashidTerri L JacksonJheanell A MorganFranklin A DwyerBeth A SchropeJohn A ChabotMichael D KlugerPublished in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2018)
The use of a direct oral anticoagulant as extended venous thromboembolism prophylaxis after major gastrointestinal surgery has not been studied to date. These results show dabigatran to be a safe alternative to low-molecular-weight heparin for extended venous thromboembolism prophylaxis with regard to bleeding complications.